Journal of Experimental Medicine, Vol 176, 67-77, Copyright © 1992 by Rockefeller University Press

ARTICLES

Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes

LS Wicker, MC Appel, F Dotta, A Pressey, BJ Miller, NH DeLarato, PA Fischer, RC Boltz Jr and LB Peterson
Department of Autoimmune Diseases Research, Merck Research Laboratories, Rahway, New Jersey 07065.

The development of autoimmune diabetes in the nonobese diabetic (NOD) mouse is controlled by multiple genes. At least one diabetogenic gene is linked to the major histocompatibility complex (MHC) of the NOD and is most likely represented by the two genes encoding the alpha and beta chains of the unique NOD class II molecule. Three other diabetogenic loci have recently been identified in the NOD mouse and are located on chromosomes 1, 3, and 11. In addition to the autoimmune diabetes which is caused by destruction of the insulin-producing beta cells in the pancreas, other manifestations of autoimmunity are seen in the NOD mouse. These include mononuclear cell inflammation of the submandibular and lacrimal glands, as well as the presence of circulating autoantibodies. To determine the effect of the non-MHC diabetogenic genes on the development of autoimmunity, we constructed the NOD.B10-H- 2b (NOD.H-2b) strain, which possesses the non-MHC diabetogenic genes from the NOD mouse, but derives its MHC from the C57BL/10 (B10) strain. The NOD.H-2b strain does not develop insulitis, cyclophosphamide- induced diabetes, or spontaneous diabetes. It does, however, develop extensive lymphocytic infiltrates in the pancreas and the submandibular glands that are primarily composed of Thy 1.2+ T cells and B220+ B cells. In addition, autoantibodies are present in NOD.H-2b mice which recognize the "polar antigen" on the insulin-secreting rat tumor line RINm38. These observations demonstrate that the non-MHC genes in the NOD strain, in the absence of the NOD MHC, significantly contribute to the development of autoimmunity. The contribution of a single dose of the NOD MHC to autoimmunity was assessed with a (NOD x NOD.H-2b)F1 cross. Although only approximately 3% of F1 females developed spontaneous diabetes, approximately 50% of both female and male F1 mice developed insulitis, and 25% of females and 17% of males became diabetic after treatment with cyclophosphamide. These data demonstrate that the MHC-linked diabetogenic genes of the NOD mouse are dominant with decreasing levels of penetrance for the following phenotypes: insulitis greater than cyclophosphamide-induced diabetes greater than spontaneous diabetes.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Meagher, C., Tang, Q., Fife, B. T., Bour-Jordan, H., Wu, J., Pardoux, C., Bi, M., Melli, K., Bluestone, J. A. (2008). Spontaneous Development of a Pancreatic Exocrine Disease in CD28-Deficient NOD Mice. J. Immunol. 180: 7793-7803 [Abstract] [Full Text]  
• Yoshida, T., Jiang, F., Honjo, T., Okazaki, T. (2008). PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice. Proc. Natl. Acad. Sci. USA 105: 3533-3538 [Abstract] [Full Text]  
• Doyle, M. E., Boggs, L., Attia, R., Cooper, L. R., Saban, D. R., Nguyen, C. Q., Peck, A. B. (2007). Autoimmune Dacryoadenitis of NOD/LtJ Mice and Its Subsequent Effects on Tear Protein Composition. Am. J. Pathol. 171: 1224-1236 [Abstract] [Full Text]  
• Chen, Y.-G., Silveira, P. A., Osborne, M. A., Chapman, H. D., Serreze, D. V. (2007). Cellular Expression Requirements for Inhibition of Type 1 Diabetes by a Dominantly Protective Major Histocompatibility Complex Haplotype. Diabetes 56: 424-430 [Abstract] [Full Text]  
• Jiang, W., Anderson, M. S., Bronson, R., Mathis, D., Benoist, C. (2005). Modifier loci condition autoimmunity provoked by Aire deficiency. JEM 202: 805-815 [Abstract] [Full Text]  
• Beilhack, G. F., Landa, R. R., Masek, M. A., Shizuru, J. A. (2005). Prevention of Type 1 Diabetes with Major Histocompatibility Complex-Compatible and Nonmarrow Ablative Hematopoietic Stem Cell Transplants. Diabetes 54: 1770-1779 [Abstract] [Full Text]  
• Ivakine, E. A., Fox, C. J., Paterson, A. D., Mortin-Toth, S. M., Canty, A., Walton, D. S., Aleksa, K., Ito, S., Danska, J. S. (2005). Sex-Specific Effect of Insulin-Dependent Diabetes 4 on Regulation of Diabetes Pathogenesis in the Nonobese Diabetic Mouse. J. Immunol. 174: 7129-7140 [Abstract] [Full Text]  
• Salam, M. A., Matin, K., Matsumoto, N., Tsuha, Y., Hanada, N., Senpuku, H. (2004). E2f1 Mutation Induces Early Onset of Diabetes and Sjogren's Syndrome in Nonobese Diabetic Mice. J. Immunol. 173: 4908-4918 [Abstract] [Full Text]  
• Takaki, T., Lieberman, S. M., Holl, T. M., Han, B., Santamaria, P., Serreze, D. V., DiLorenzo, T. P. (2004). Requirement for Both H-2Db and H-2Kd for the Induction of Diabetes by the Promiscuous CD8+ T Cell Clonotype AI4. J. Immunol. 173: 2530-2541 [Abstract] [Full Text]  
• Salam, M. A., Matsumoto, N., Matin, K., Tsuha, Y., Nakao, R., Hanada, N., Senpuku, H. (2004). Establishment of an Animal Model Using Recombinant NOD.B10.D2 Mice To Study Initial Adhesion of Oral Streptococci. CVI 11: 379-386 [Abstract] [Full Text]  
• Serreze, D. V., Holl, T. M., Marron, M. P., Graser, R. T., Johnson, E. A., Choisy-Rossi, C., Slattery, R. M., Lieberman, S. M., DiLorenzo, T. P. (2004). MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells That Are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice. J. Immunol. 172: 871-879 [Abstract] [Full Text]  
• Morgan, D. J., Nugent, C. T., Raveney, B. J. E., Sherman, L. A. (2004). In a Transgenic Model of Spontaneous Autoimmune Diabetes, Expression of a Protective Class II MHC Molecule Results in Thymic Deletion of Diabetogenic CD8+ T Cells. J. Immunol. 172: 1000-1008 [Abstract] [Full Text]  
• Pearson, T., Markees, T. G., Serreze, D. V., Pierce, M. A., Marron, M. P., Wicker, L. S., Peterson, L. B., Shultz, L. D., Mordes, J. P., Rossini, A. A., Greiner, D. L. (2003). Genetic Disassociation of Autoimmunity and Resistance to Costimulation Blockade-Induced Transplantation Tolerance in Nonobese Diabetic Mice. J. Immunol. 171: 185-195 [Abstract] [Full Text]  
• Beilhack, G. F., Scheffold, Y. C., Weissman, I. L., Taylor, C., Jerabek, L., Burge, M. J., Masek, M. A., Shizuru, J. A. (2003). Purified Allogeneic Hematopoietic Stem Cell Transplantation Blocks Diabetes Pathogenesis in NOD Mice. Diabetes 52: 59-68 [Abstract] [Full Text]  
• Marron, M. P., Graser, R. T., Chapman, H. D., Serreze, D. V. (2002). Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc. Natl. Acad. Sci. USA 99: 13753-13758 [Abstract] [Full Text]  
• Boulard, O., Damotte, D., Deruytter, N., Fluteau, G., Carnaud, C., Garchon, H.-J. (2002). An Interval Tightly Linked to but Distinct From the H2 Complex Controls Both Overt Diabetes (Idd16) and Chronic Experimental Autoimmune Thyroiditis (Ceat1) in Nonobese Diabetic Mice. Diabetes 51: 2141-2147 [Abstract] [Full Text]  
• Thiessen, S., Serra, P., Amrani, A., Verdaguer, J., Santamaria, P. (2002). T-Cell Tolerance by Dendritic Cells and Macrophages as a Mechanism for the Major Histocompatibility Complex-Linked Resistance to Autoimmune Diabetes. Diabetes 51: 325-338 [Abstract] [Full Text]  
• Chiu, P. P. L., Jevnikar, A. M., Danska, J. S. (2001). Genetic Control of T and B Lymphocyte Activation in Nonobese Diabetic Mice. J. Immunol. 167: 7169-7179 [Abstract] [Full Text]  
• Trembleau, S., Gregori, S., Penna, G., Gorny, I., Adorini, L. (2001). IL-12 Administration Reveals Diabetogenic T Cells in Genetically Resistant I-E{alpha}-Transgenic Nonobese Diabetic Mice: Resistance to Autoimmune Diabetes Is Associated with Binding of E{alpha}-Derived Peptides to the I-Ag7 Molecule. J. Immunol. 167: 4104-4114 [Abstract] [Full Text]  
• Koarada, S., Wu, Y., Ridgway, W. M. (2001). Increased Entry into the IFN-{gamma} Effector Pathway by CD4+ T Cells Selected by I-Ag7 on a Nonobese Diabetic Versus C57BL/6 Genetic Background. J. Immunol. 167: 1693-1702 [Abstract] [Full Text]  
• Yamakawa, M., Weinstein, R., Tsuji, T., McBride, J., Wong, D. T. W., Login, G. R. (2000). Age-related Alterations in IL-1{beta}, TNF-{alpha}, and IL-6 Concentrations in Parotid Acinar Cells from BALB/c and Non-obese Diabetic Mice. J. Histochem. Cytochem. 48: 1033-1042 [Abstract] [Full Text]  
• Jordan, M. A., Silveira, P. A., Shepherd, D. P., Chu, C., Kinder, S. J., Chen, J., Palmisano, L. J., Poulton, L. D., Baxter, A. G. (2000). Linkage Analysis of Systemic Lupus Erythematosus Induced in Diabetes-Prone Nonobese Diabetic Mice by Mycobacterium bovis. J. Immunol. 165: 1673-1684 [Abstract] [Full Text]  
• Kanagawa, O., Xu, G., Tevaarwerk, A., Vaupel, B. A. (2000). Protection of Nonobese Diabetic Mice from Diabetes by Gene(s) Closely Linked to IFN-{gamma} Receptor Loci. J. Immunol. 164: 3919-3923 [Abstract] [Full Text]  
• Noorchashm, H., Lieu, Y. K., Noorchashm, N., Rostami, S. Y., Greeley, S. A. S., Schlachterman, A., Song, H. K., Noto, L. E., Jevnikar, A. M., Barker, C. F., Naji, A. (1999). I-Ag7-Mediated Antigen Presentation by B Lymphocytes Is Critical in Overcoming a Checkpoint in T Cell Tolerance to Islet {beta} Cells of Nonobese Diabetic Mice. J. Immunol. 163: 743-750 [Abstract] [Full Text]  
• Guerder, S., Eynon, E. E., Flavell, R. A. (1998). Autoimmunity Without Diabetes in Transgenic Mice Expressing {beta} Cell-Specific CD86, But Not CD80: Parameters that Trigger Progression to Diabetes. J. Immunol. 161: 2128-2140 [Abstract] [Full Text]  
• Robinson, C. P., Brayer, J., Yamachika, S., Esch, T. R., Peck, A. B., Stewart, C. A., Peen, E., Jonsson, R., Humphreys-Beher, M. G. (1998). Transfer of human serum IgG to nonobese diabetic Igµnull mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome. Proc. Natl. Acad. Sci. USA 95: 7538-7543 [Abstract] [Full Text]  
• Melanitou, E., Joly, F., Lathrop, M., Boitard, C., Avner, P. (1998). Evidence for the Presence of Insulin-Dependent Diabetes-Associated Alleles on the Distal Part of Mouse Chromosome 6. Genome Res 8: 608-620 [Abstract] [Full Text]  
• Luhder, F., Katz, J., Benoist, C., Mathis, D. (1998). Major Histocompatibility Complex Class II Molecules Can Protect from Diabetes by Positively Selecting T Cells with Additional Specificities. JEM 187: 379-387 [Abstract] [Full Text]  
• Verdaguer, J., Schmidt, D., Amrani, A., Anderson, B., Averill, N., Santamaria, P. (1997). Spontaneous Autoimmune Diabetes in Monoclonal T Cell Nonobese Diabetic Mice. JEM 186: 1663-1676 [Abstract] [Full Text]  
• Wicker, L. S. (1997). Major Histocompatibility Complex-linked Control of Autoimmunity. JEM 186: 973-975 [Full Text]  
• Schmidt, D., Verdaguer, J., Averill, N., Santamaria, P. (1997). A Mechanism for the Major Histocompatibility Complex-linked Resistance to Autoimmunity. JEM 186: 1059-1075 [Abstract] [Full Text]  
• Thomas-Vaslin, V., Damotte, D., Coltey, M., Le Douarin, N. M., Coutinho, A., Salaun, J. (1997). Abnormal T cell selection on nod thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice. Proc. Natl. Acad. Sci. USA 94: 4598-4603 [Abstract] [Full Text]  
• Prins, J., Todd, J., Rodrigues, N., Ghosh, S, Hogarth, P., Wicker, L., Gaffney, E, Podolin, P., Fischer, P., Sirotina, A, et, al. (1993). Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science 260: 695-698 [Abstract]  
• Salaun, J., Simmenauer, N., Belo, P., Coutinho, A., Le Douarin, N. M. (2002). Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes. Proc. Natl. Acad. Sci. USA 99: 874-877 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS